- Daiichi Sankyo, Inc. (Bernards, NJ)
- …immune disorders. We are currently seeking a Medical Information and Education Intern for summer 2025 . This part time position works for approximately 20 hours ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision...with our outcomes lead.Additionally, we have a project next summer that will be underway for the build of… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …a Global Project Management and Leadership, Asset & Portfolio Management Intern for summer 2025 . This full-time position works for approximately 37.5 hours per ... medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …diseases and immune disorders. We are currently seeking an R&D Procurement Intern for summer 2025 . This full-time position works for approximately 37.5 hours per ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision...plusQualified candidates must currently be enrolled in an accredited undergraduate program with a concentration in science or related… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …and immune disorders. We are currently seeking a Regulatory Affairs Intern for summer 2025 . This full-time position works for approximately 37.5 hours per ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision...Qualified candidates must currently be enrolled in an accredited undergraduate program with a concentration in science or related… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …and immune disorders. We are currently seeking a Global Regulatory Affairs Intern for summer 2025 . This full time position works for approximately 37.5 hours per ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision...and have completed at least 3 years in an undergraduate program, or enrolled full-time in a graduate program,… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …and immune disorders. We are currently seeking a Global R&D Communications Intern for summer 2025 . This full-time position works for approximately 37.5 hours per ... medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma ... seeking a Clinical Trial Business Operations Intern for the summer of 2025 . This full time position...Qualified candidates must currently be enrolled in an accredited undergraduate program with a concentration in data management or… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …and immune disorders. We are currently seeking a Technology Management Intern for summer 2025 . This full time position works for approximately 37.5 hours ... medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …immune disorders. We are currently seeking an R&D Finance and Procurement Intern for summer 2025 . This part time position works for approximately 20 hours per ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision...Qualified candidates must currently be enrolled in an accredited undergraduate or graduate program with a concentration in science… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …disorders. We are currently seeking a Marketing/ US Oncology Business Division Intern for summer 2025 (June - August). This full time position works for ... medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma… more
